Literature DB >> 1000196

Tobramycin, amikacin, sissomicin, and gentamicin resistant Gram-negative rods.

F A Drasar, W Farrell, J Maskell, J D Williams.   

Abstract

Sensitivities to gentamicin, sissomicin, tobramycin, and amikacin were compared in 196 gentamicin-resistant Gram-negative rods and in 212 similar organisms sensitive to gentamicin, mainly isolated from clinical specimens. Amikacin was the aminoglycoside most active against gentamicin-resistant organisms, Pseudomonas aeruginosa, klebsiella spp, Escherichia coli, Proteus spp, Providencia spp, and Citrobacter spp being particularly susceptible. Most of the gentamicin-resistant organisms were isolated from the urine of patients undergoing surgery. Gentamicin was the most active antibiotic against gentamicin-sensitive E coli, Proteus mirabilis, and Serratia spp. Pseudomonas aeruginosa and other Pseudomonas spp were most susceptible to tobramycin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000196      PMCID: PMC1690042          DOI: 10.1136/bmj.2.6047.1284

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

Review 1.  Effect of structural modifications on the biological properties of aminoglycoside antibiotics containing 2-deoxystreptamine.

Authors:  K E Price; J C Godfrey
Journal:  Adv Appl Microbiol       Date:  1974       Impact factor: 5.086

2.  The in-vitro activity of tobramycin compared with that of other aminoglycosides.

Authors:  P M Waterworth
Journal:  J Clin Pathol       Date:  1972-11       Impact factor: 3.411

3.  Antipseudomonal drugs: comparative study of gentamicin, sisomicin and tobramycin in vitro and in human volunteers.

Authors:  J Klastersky; A Henri; C Hensgens; L Vandenborre; D Daneau
Journal:  Eur J Cancer       Date:  1973-09       Impact factor: 9.162

4.  Letter: Gentamicin resistance.

Authors:  R H George; D E Healing
Journal:  Lancet       Date:  1976-01-31       Impact factor: 79.321

5.  Changes in antibiotic sensitivity patterns of Gram-negative bacilli in burns.

Authors:  E Roe; E J Lowbury
Journal:  J Clin Pathol       Date:  1972-02       Impact factor: 3.411

6.  Amikacin therapy for serious gram-negative bacillary infections.

Authors:  R D Meyer; R P Lewis; E D Carmalt; S M Finegold
Journal:  Ann Intern Med       Date:  1975-12       Impact factor: 25.391

7.  Comparative activity of sisomicin, gentamicin, kanamycin, and tobramycin.

Authors:  J A Waitz; E L Moss; C G Drube; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

8.  Gentamicin-resistant Pseudomonas aeruginosa and Serratia marcescens in a general hospital.

Authors:  R D Meyer; R P Lewis; J Halter; M White
Journal:  Lancet       Date:  1976-03-13       Impact factor: 79.321

9.  Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.

Authors:  A V Reynolds; J M Hamilton-Miller; W Brumfitt
Journal:  Br Med J       Date:  1974-09-28

10.  Sisomicin: evaluation in vitro and comparison with gentamicin and tobramycin.

Authors:  C C Crowe; E Sanders
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

View more
  5 in total

1.  Emergence in a burn center of populations of bacteria resistant to gentamicin, tobramycin, and amikacin: evidence for the need for changes in zone diameter interpretative standards.

Authors:  B H Minshew; H M Pollock; F D Schoenknecht; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1977-12       Impact factor: 5.191

2.  Surveillance of gentamicin-resistant gram-negative bacilli in a general hospital.

Authors:  C A Kauffman; N C Ramundo; S G Williams; C R Dey; J P Phair; C Watanakunakorn
Journal:  Antimicrob Agents Chemother       Date:  1978-06       Impact factor: 5.191

3.  In vitro susceptibility of gentamicin and/or tobramycin resistant gram-negative bacilli to seven aminoglycosides.

Authors:  C Watanakunakorn; C A Kauffman
Journal:  Infection       Date:  1978       Impact factor: 3.553

4.  Flavobacterium odoratum: a species resistant to a wide range of antimicrobial agents.

Authors:  B Holmes; J J Snell; S P Lapage
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

5.  The sensitivity of gentamicin-resistant gram-negative bacilli to cefotaxime, other cephalosporins and aminoglycosides.

Authors:  M Stephens; M Potten; A J Bint
Journal:  Infection       Date:  1979       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.